IRMD - Iradimed Co logo

Iradimed Co

IRMD

Iradimed Corporation develops and distributes MRI-compatible intravenous infusion pump systems and patient vital signs monitoring systems, along with related accessories, serving hospitals and imaging centers through direct sales and distributors.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$5,588today

Score Overview

1 Year
Score
Net Growth2.56%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth3.01%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score8.7
Net Growth147.22%
Net TrendEvery year
Net Income Consistencyโ€”
Rev Growth106.48%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth219.56%
Net Trend80%
Net Income Consistency
Rev Growth165.69%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth11x
Net Trend75%
Net Income Consistency
Rev Growth451.58%
Rev Trend83%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Iradimed Co has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 20 years of fundamentals. IRMD does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-30
$ 86.22โ€”
1 Year2025-09-30
$ 70.1922.84%
5 Years2021-09-30
$ 30.50182.64%
10 Years2016-09-30
$ 15.43458.80%
All Time2014-07-16
$ 8.999x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 86M$ 23M$ 59M
2025$ 83M$ 22M$ 51M
2024$ 73M$ 19M$ 52M
2023$ 65M$ 17M$ 49M
2022$ 53M$ 12M$ 57M
2021$ 41M$ 9M$ 62M
2020$ 31M$ 1M$ 51M
2019$ 38M$ 9M$ 46M
2018$ 30M$ 6M$ 34M
2017$ 23M$ 499.76K$ 26M
2016$ 32M$ 7M$ 25M
2015$ 31M$ 7M$ 26M
IPO2014$ 15M$ 2M$ 17M
IRMD - Iradimed Co logo

Iradimed Co fundamental performance

Between 2020 and 2025, revenue grew from $ 31M to $ 83M and net income grew from $ 1M to $ 22M. Revenue increased in every one of those 5 years; net income in every one.

Between 2015 and 2025, revenue grew from $ 31M to $ 83M and net income grew from $ 7M to $ 22M. Revenue increased in 8 of those 10 years; net income in 8.

Iradimed Co currently holds a 5-year HDB Score of 8.7 out of 10. How the HDB Score is calculated.

Membership

Explore IRMD with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,814 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies